Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
Public ClinicalTrials.gov record NCT00909181. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Parallel, Placebo-Controlled, Multicenter Study Evaluating the Effect of Treatment With Topically Administered Oxybutynin Gel in Patients With Urinary Frequency, and Urge and Mixed Urinary Incontinence With a Predominance of Urge Incontinence Episodes With an Open-Label Extension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of the double-blind phase of the study is to compare the effects of two doses of oxybutynin gel to placebo gel. The objective of the open-label extension is to evaluate the extended safety and skin-irritation profile of topically administered oxybutynin gel. The hypothesis is that topically administered oxybutynin gel will decrease (compared to placebo) the number of incontinence episodes per week, average daily urinary frequency, and urinary urgency; increase average urinary void volume; and improve patient quality of life.
Study identification
- NCT ID
- NCT00909181
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 626 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2009 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Nov 2010 (Actual)
- Last update posted
- Jul 2, 2014
2009 – 2010
United States locations
- U.S. sites
- 55
- U.S. states
- 26
- U.S. cities
- 53
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35233 | — |
| Not listed | Little Rock | Arkansas | 72211 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Los Angeles | California | 90048 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92120 | — |
| Not listed | Farmington | Connecticut | 06032 | — |
| Not listed | New Britain | Connecticut | 06052 | — |
| Not listed | New Port Richey | Florida | 34625 | — |
| Not listed | North Miami | Florida | 33161 | — |
| Not listed | Pembroke Pines | Florida | 33024 | — |
| Not listed | Sarasota | Florida | 34232 | — |
| Not listed | St. Petersburg | Florida | 33710 | — |
| Not listed | Tampa | Florida | 33607 | — |
| Not listed | Wellington | Florida | 33414 | — |
| Not listed | Columbus | Georgia | 31904 | — |
| Not listed | Sandy Springs | Georgia | 30328 | — |
| Not listed | Stockbridge | Georgia | 30281 | — |
| Not listed | Evanston | Illinois | 60201 | — |
| Not listed | West Des Moines | Iowa | 50266 | — |
| Not listed | Shreveport | Louisiana | 71106 | — |
| Not listed | Annapolis | Maryland | 21401 | — |
| Not listed | Towson | Maryland | 21204 | — |
| Not listed | Watertown | Massachusetts | 02472 | — |
| Not listed | Grand Rapids | Michigan | 49503 | — |
| Not listed | Saginaw | Michigan | 48604 | — |
| Not listed | Chesterfield | Missouri | 63017 | — |
| Not listed | Las Vegas | Nevada | 89130 | — |
| Not listed | Brooklyn | New York | 11211 | — |
| Not listed | Endwell | New York | 13760 | — |
| Not listed | Kingston | New York | 12401 | — |
| Not listed | Poughkeepsie | New York | 12601 | — |
| Not listed | Williamsville | New York | 14221 | — |
| Not listed | Cary | North Carolina | 27518 | — |
| Not listed | Charlotte | North Carolina | 28209 | — |
| Not listed | Harrisburg | North Carolina | 28075 | — |
| Not listed | Raleigh | North Carolina | 27607 | — |
| Not listed | Raleigh | North Carolina | 27609 | — |
| Not listed | Salisbury | North Carolina | 28144 | — |
| Not listed | Wilmington | North Carolina | 28401 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Wadsworth | Ohio | 44218 | — |
| Not listed | Bethany | Oklahoma | 73008 | — |
| Not listed | Corvallis | Oregon | 97330 | — |
| Not listed | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Not listed | Landsdale | Pennsylvania | 19446 | — |
| Not listed | Greenville | South Carolina | 29615 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Myrtle Beach | South Carolina | 29572 | — |
| Not listed | Sioux Falls | South Dakota | 57104 | — |
| Not listed | Fayetteville | Tennessee | 37334 | — |
| Not listed | Provo | Utah | 84604 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Seattle | Washington | 98104 | — |
| Not listed | Spokane | Washington | 99207 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00909181, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 2, 2014 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00909181 live on ClinicalTrials.gov.